Not Your Ordinary Pharma Company
Sen-Jam Pharmaceutical makes affordable, safe drugs that work.
This isn’t your ordinary pharma company. It’s a group of scientists, pharmacists, and pain experts on a mission to bring the world medications that are safe, effective, and affordable.
The company’s treatments center around inflammation, believed to be the root cause of many ailments. Despite this theory, consumers don’t have many options that address inflammation.
Sen-Jam has repurposed two small molecules that have an effect on inflammation, helping to prevent problems before they need solving. The company’s lead creations include oral therapeutics for Covid-19, opioid withdrawal, and alcohol-related hangover prevention. This represents a seventeen-billion-dollar opportunity in the U.S.
Sen-Jam is on an accelerated 505(b) regulatory pathway. Its immediate goal is to move forward with clinical trials, with plans to sell and license its medications by 2025.
Just enter your e-mail address below & get this guide instantly
No thanks, I’d like to continue making next to nothing in the stock market.
